| 1 |
35220154 | The role of tranexamic acid in traumatic brain injury. | 2022 May |
2 |
| 2 |
35323992 | The uses of tranexamic acid in dermatology: a review. | 2022 Mar 24 |
1 |
| 3 |
35388589 | Adjunctive treatment for acne vulgaris by tranexamic acid. | 2022 Apr 7 |
2 |
| 4 |
35557600 | Encouragement for Further Study of Tranexamic Acid Administration for Sacroiliac Joint Fusion Surgery. | 2022 |
1 |
| 5 |
33001565 | Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery. | 2021 Jan |
3 |
| 6 |
33164754 | Tranexamic acid for ACE inhibitor induced angioedema. | 2021 May |
2 |
| 7 |
33443933 | Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo. | 2021 Apr 1 |
6 |
| 8 |
33518674 | Tranexamic Acid Improves the Disrupted Formation of Collagen and Fibrillin-1 Fibers Produced by Fibroblasts Repetitively Irradiated with UVA. | 2021 |
2 |
| 9 |
34035635 | High-dose Continuous Infusion of Tranexamic Acid for Controlling Life-threatening Bleed in Advanced Cancer Patients. | 2021 Jan-Mar |
6 |
| 10 |
34065949 | Plasmin, Immunity, and Surgical Site Infection. | 2021 May 12 |
1 |
| 11 |
34703327 | Utilization of Tranexamic Acid in Surgical Orthopaedic Practice: Indications and Current Considerations. | 2021 |
2 |
| 12 |
35095503 | Repurposing Tranexamic Acid as an Anticancer Agent. | 2021 |
7 |
| 13 |
31658420 | Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding. | 2020 Feb 27 |
1 |
| 14 |
32064426 | Pericardial Tamponade After Systemic Alteplase in Stroke and Emergent Reversal With Tranexamic Acid. | 2020 Feb |
2 |
| 15 |
32567734 | Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single-centre, triple-blind, randomized, placebo-control, parallel group study. | 2020 Nov |
1 |
| 16 |
32701529 | Tranexamic Acid for Melasma Treatment: A Split-Face Study. | 2020 Nov |
2 |
| 17 |
32732500 | Tranexamic acid is associated with reduced complement activation in trauma patients with hemorrhagic shock and hyperfibrinolysis on thromboelastography. | 2020 Dec |
2 |
| 18 |
32819728 | [Comparison of two doses of intra-articular tranexamic acid on postoperative bleeding in total knee arthroplasty: a randomized clinical trial]. | 2020 Jul - Aug |
2 |
| 19 |
33208180 | Prospective randomized trial comparing efficacy and safety of intravenous and intra-articular tranexamic acid in total knee arthroplasty. | 2020 Nov 18 |
2 |
| 20 |
33230046 | Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid? | 2020 Dec |
1 |
| 21 |
30451372 | Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay. | 2019 Jan |
5 |
| 22 |
30575685 | Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner. | 2019 Jan |
10 |
| 23 |
31126915 | Tranexamic acid modulates the immune response and reduces postsurgical infection rates. | 2019 May 28 |
4 |
| 24 |
31141852 | Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation | 2019 May 1 |
2 |
| 25 |
31489276 | Tranexamic Acid Use in a Patient with a Life-threatening Bleed Exacerbated by Coagulopathy Due to an Aortic Aneurysm with an Endoleak: A Case Report. | 2019 Aug 26 |
2 |
| 26 |
28678111 | Effectiveness and Safety of Batroxobin, Tranexamic Acid and a Combination in Reduction of Blood Loss in Lumbar Spinal Fusion Surgery. | 2018 Mar 1 |
1 |
| 27 |
29498767 | Dermal fibroblasts can activate matrix metalloproteinase-1 independent of keratinocytes via plasmin in a 3D collagen model. | 2018 May |
2 |
| 28 |
29926296 | The ratio of concentrations of aminocaproic acid and tranexamic acid that prevent plasmin activation of platelets does not provide equivalent inhibition of plasmatic fibrinolysis. | 2018 Oct |
1 |
| 29 |
30253023 | Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study. | 2018 Sep |
2 |
| 30 |
27173008 | Oral tranexamic acid lightens refractory melasma. | 2017 Aug |
1 |
| 31 |
28601310 | Hemoglobin-based oxygen carriers promote systemic hyperfibrinolysis that is both dependent and independent of plasmin. | 2017 Jun 1 |
2 |
| 32 |
29296720 | X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors. | 2017 May 9 |
5 |
| 33 |
29354728 | Efficacy of tranexamic acid in reducing blood loss and blood transfusion in idiopathic scoliosis: a systematic review and meta-analysis. | 2017 Dec |
1 |
| 34 |
24756178 | Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty. | 2015 Jan |
2 |
| 35 |
25747626 | TXA in combat casualty care--does it adversely affect extremity reconstruction and flap thrombosis rates? | 2015 Mar |
2 |
| 36 |
26177992 | Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma. | 2015 Sep |
2 |
| 37 |
26538719 | Oral Tranexamic Acid with Fluocinolone-Based Triple Combination Cream Versus Fluocinolone-Based Triple Combination Cream Alone in Melasma: An Open Labeled Randomized Comparative Trial. | 2015 Sep-Oct |
1 |
| 38 |
23967870 | Tranexamic acid accelerates skin barrier recovery and upregulates occludin in damaged skin. | 2014 Aug |
2 |
| 39 |
24659483 | Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders. | 2014 Nov |
1 |
| 40 |
22329442 | Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. | 2013 Aug |
2 |
| 41 |
23261456 | Involvement of plasmin-mediated extracellular activation of progalanin in angiogenesis. | 2013 Jan 18 |
1 |
| 42 |
23661406 | Antifibrinolytic agents in current anaesthetic practice. | 2013 Oct |
1 |
| 43 |
21707521 | Plasmin: its role in the extracellular processing of progalanin in tumor tissue. | 2011 Dec |
1 |
| 44 |
20185649 | Temporally and regionally disparate differences in plasmin activity by tranexamic acid. | 2010 Mar 1 |
3 |
| 45 |
19104179 | CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties. | 2009 Jan |
1 |
| 46 |
19207486 | Tranexamic acid can inhibit tongue squamous cell carcinoma invasion in vitro. | 2009 Mar |
1 |
| 47 |
18460030 | Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. | 2008 Jul |
2 |
| 48 |
16227196 | Review and application of serine protease inhibition in coronary artery bypass graft surgery. | 2005 Sep 15 |
1 |
| 49 |
12846058 | No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study. | 2003 May-Jun |
2 |
| 50 |
14572819 | Protease inhibitors in the treatment of hereditary angioedema. | 2003 Dec |
1 |